The risk of developing non-melanoma skin cancer, lymphoma and melanoma in patients with psoriasis in Taiwan: A 10-year, population-based cohort study

International Journal of Dermatology

Volumn 51, Issue 12, 2012, Pages 1454-1460

  Lee, Meng Sui ^a   Lin, Ruey Yi ^a   Chang, Yun Ting ^b,c   Lai, Mei Shu ^d  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CHILD; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INFANT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; NON MELANOMA SKIN CANCER; POPULATION; PRESCHOOL CHILD; PSORIASIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX DIFFERENCE; TAIWAN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LYMPHOMA; MALE; MELANOMA; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PSORIASIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SKIN NEOPLASMS; TAIWAN; YOUNG ADULT;

EID: 84869808499     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.05310.x     Document Type: Article

References (42)

1. Dunnick JK, Forbes PD, Eustis SL, et al. Tumors of the skin in the hra/skh mouse after treatment with 8-methoxypsoralen and uva radiation. Fundam Appl Toxicol 1991; 16: 92-102.
2. Glover MT, Deeks JJ, Raftery MJ, et al. Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients. Lancet 1997; 349: 398.
3. Wang XM, McNiff JM, Klump V, et al. An unexpected spectrum of p53 mutations from squamous cell carcinomas in psoriasis patients treated with puva. Photochem Photobiol 1997; 66: 294-299.
4. Chapel H, Haeney M, Misbah S, et al. In: Essentials of Clinical Immunology, 5th edn. Oxford: Wiley-Blackwell, 2006: 358.
5. Frentz G, Olsen JH. Malignant tumours and psoriasis: a follow-up study. Br J Dermatol 1999; 140: 237-242.
6. Hannuksela-Svahn A, Pukkala E, Laara E, et al. Psoriasis, its treatment, and cancer in a cohort of finnish patients. J Invest Dermatol 2000; 114: 587-590.
7. Boffetta P, Gridley G, Lindelof B. Cancer risk in a population-based cohort of patients hospitalized for psoriasis in sweden. J Invest Dermatol 2001; 117: 1531-1537.
8. Stern RS, Lange R. Non-melanoma skin cancer occurring in patients treated with puva five to ten years after first treatment. J Invest Dermatol 1988; 91: 120-124.
9. Stern RS, Laird N. The carcinogenetic risk of treatments for severe psoriasis. Cancer 1994; 73: 2759-2764.
10. Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet a radiation (puva). New England J Med 1997; 336: 1041-1045.
11. Stern RS. The risk of melanoma in association with long-term exposure to puva. J Am Acad Dermatol 2001; 44: 755-761.
12. Stern RS. Lymphoma risk in psoriasis: results of the puva follow-up study. Arch Dermatol 2006; 142: 1132-1135.
13. Kawada A, Tezuka T, Nakamizo Y, et al. A survey of psoriasis patients in japan from 1982 to 2001. J Dermatol Sci 2003; 31: 59-64.
14. Chang YT, Chen TJ, Liu PC, et al. Epidemiological study of psoriasis in the national health insurance database in taiwan. Acta Derm Venereol 2009; 89: 262-266.
15. Gelfand JM, Shin DB, Neimann AL, et al. The risk of lymphoma in patients with psoriasis. J Invest Dermatol 2006; 126: 2194-2201.
16. Kung YY, Chen YC, Hwang SJ, et al. The prescriptions frequencies and patterns of chinese herbal medicine for allergic rhinitis in taiwan. Allergy 2006; 61: 1316-1318.
17. Hsin-Wei K, Shang-Shyue T, Mao-Meng T, et al. Epidemiological features of ckd in taiwan. Am J Kidney Dis 2007; 49: 46-55.
18. Wang Y-C, Lin J-M, Li C-Y, et al. Prevalence and risks of chronic airway obstruction. Chest 2007; 131: 705-710.
19. Chen YJ, Wu CY, Huang YL, et al. Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in taiwan. Arthritis Res Ther 2010; 12: R70.
20. Gelfand JM, Dommasch ED, Shin DB, et al. The risk of stroke in patients with psoriasis. J Invest Dermatol 2009; 129: 2411-2418.
21. Gelfand JM, Troxel AB, Lewis JD, et al. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 2007; 143: 1493-1499.
22. Mehta N, Azfar R, Shin D. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the general practice research database. Eur Heart J 2009; 31: 1000-1006.
23. Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-1741.
24. Marcil I, Stern RS. Squamous-cell cancer of the skin in patients given puva and ciclosporin: nested cohort crossover study. Lancet 2001; 358: 1042-1045.
25. Paul CF, Ho VC, McGeown C, et al. Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study. J Invest Dermatol 2003; 120: 211-216.
26. Lindelof B, Sigurgeirsson B. Puva and cancer - a case-control study. Br J Dermatol 1993; 129: 39-41.
27. Hayes J, Koo J. Psoriasis: depression, anxiety, smoking, and drinking habits. Dermatol Ther 2010; 23: 174-180.
28. Gerdes S, Zahl VA, Weichenthal M, et al. Smoking and alcohol intake in severely affected patients with psoriasis in germany. Dermatology 2010; 220: 38-43.
29. Krueger JG, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005; 64(Suppl. 2): ii30-ii36.
30. Mahmoud F, Abul H, Al Saleh Q, et al. Elevated b-lymphocyte levels in lesional tissue of non-arthritic psoriasis. J Dermatol 1999; 26: 428-433.
31. Ekstrom K, Hjalgrim H, Brandt L, et al. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. Arthritis Rheum 2003; 48: 963-970.
32. Gelfand JM, Berlin J, Van Voorhees A, et al. Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the united kingdom. Arch Dermatol 2003; 139: 1425-1429.
33. Whitmore SE. Methotrexate and risk for lymphoma. Arch Dermatol 2007; 143: 663-664.
34. Silman AJ, Petrie J, Hazleman B, et al. Lymphoproliferative cancer and other malignancy in patients with rheumatoid-arthritis treated with azathioprine - a 20 year follow up study. Annals Rheum Dis 1988; 47: 988-992.
35. Suzuki T, Ueda M, Ogata K, et al. Doses of solar ultraviolet radiation correlate with skin cancer rates in japan. Kobe J Med Sci 1996; 42: 375-388.
36. Qureshi AA, Laden F, Colditz GA, et al. Geographic variation and risk of skin cancer in us women: differences between melanoma, squamous cell carcinoma, and basal cell carcinoma. Arch Internal Med 2008; 168: 501-507.
37. Almahroos M, Kurban AK. Ultraviolet carcinogenesis in nonmelanoma skin cancer. Part i: incidence rates in relation to geographic locations and in migrant populations. Skinmed 2004; 3: 29-35.
38. Corrêa MP, Dubuisson P, Plana-Fattori A. An overview of the ultraviolet index and the skin cancer cases in brazil. Photochem Photobiol 2003; 78: 49-54.
39. Oliveria SA, Saraiya M, Geller AC, et al. Sun exposure and risk of melanoma. Arch Dis Childhood 2006; 91: 131-138.
40. Lee JA. Declining effect of latitude on melanoma mortality rates in the United States. A preliminary study. Am J Epidemiol 1997; 146: 413-417.
41. Chen YJ, Wu CY, Chen JT, et al. Clinicopathologic analysis of malignant melanoma in Taiwan. J Am Acad Dermatol 1999; 41: 945-949.
42. Nagore E, Pereda C, Botella-Estrada R, et al. Acral lentiginous melanoma presents distinct clinical profile with high cancer susceptibility. Cancer Causes Control 2009; 20: 115-119.